| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |